Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for ResMed Inc. (RMD:NYSE), powered by AI.
ResMed Inc. is currently trading at $193.94. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for ResMed Inc. on Alpha Lenz.
View ResMed Inc.'s valuation metrics on Alpha Lenz.
“ResMed Inc.'s ROE is 25.9%. Explore profitability and growth together.”
Ask for details →ResMed Inc. is an innovative leader in the development and manufacturing of devices focused on improving the quality of sleep and respiratory health. Operating globally, ResMed specializes in producing advanced equipment for sleep apnea therapy, chronic obstructive pulmonary disease (COPD), and various respiratory conditions. The company's offerings include a range of cutting-edge products like continuous positive airway pressure (CPAP) devices, bilevel systems, and ventilators, designed to enhance patient comfort and compliance. ResMed is also at the forefront of integrating cloud-connected devices to support improved patient monitoring and telemedicine services. The healthcare industry, particularly the medical device sector, benefits significantly from ResMed's contributions, as the company aims to address the growing needs associated with sleep and respiratory conditions. By focusing on both personal and overarching health care solutions, ResMed plays a crucial role in enhancing patient quality of life, thereby solidifying its position as a key player in the global health and respiratory care markets.
“ResMed Inc.'s ROE is 25.9%. Explore profitability and growth together.”
Ask for details →ResMed Inc. (ticker: RMD) is a company listed on NYSE in the Healthcare sector (Medical Instruments & Supplies). It has approximately 10,600 employees.
The current price is $193.94 with a P/E ratio of -x and P/B of -x.
ROE is 25.86% and operating margin is 32.79%. Annual revenue is $5.1B.